PT1166775E - Distribuição génica lipossomal direccionada - Google Patents

Distribuição génica lipossomal direccionada Download PDF

Info

Publication number
PT1166775E
PT1166775E PT01123562T PT01123562T PT1166775E PT 1166775 E PT1166775 E PT 1166775E PT 01123562 T PT01123562 T PT 01123562T PT 01123562 T PT01123562 T PT 01123562T PT 1166775 E PT1166775 E PT 1166775E
Authority
PT
Portugal
Prior art keywords
gene delivery
targeted liposome
liposome gene
virus
targeted
Prior art date
Application number
PT01123562T
Other languages
English (en)
Inventor
Esther H Chang
Liang Xu
Kathleen Pirollo
Original Assignee
Univ Georgetown
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Georgetown filed Critical Univ Georgetown
Publication of PT1166775E publication Critical patent/PT1166775E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0008—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition
    • A61K48/0025—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition wherein the non-active part clearly interacts with the delivered nucleic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/88—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Dispersion Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
PT01123562T 1997-11-19 1998-11-19 Distribuição génica lipossomal direccionada PT1166775E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6618897P 1997-11-19 1997-11-19
US8317598P 1998-04-27 1998-04-27

Publications (1)

Publication Number Publication Date
PT1166775E true PT1166775E (pt) 2010-04-16

Family

ID=26746455

Family Applications (1)

Application Number Title Priority Date Filing Date
PT01123562T PT1166775E (pt) 1997-11-19 1998-11-19 Distribuição génica lipossomal direccionada

Country Status (12)

Country Link
EP (2) EP1166775B1 (pt)
JP (2) JP2001522871A (pt)
CN (3) CN1616665B (pt)
AT (2) ATE459340T1 (pt)
AU (1) AU759164C (pt)
CA (1) CA2308584C (pt)
DE (2) DE69830249T2 (pt)
DK (1) DK1166775T3 (pt)
ES (1) ES2339421T3 (pt)
HK (3) HK1035490A1 (pt)
PT (1) PT1166775E (pt)
WO (1) WO1999025320A1 (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8617514B2 (en) 1999-02-22 2013-12-31 Georgetown University Tumor-targeted nanodelivery systems to improve early MRI detection of cancer
JP4799736B2 (ja) 1999-02-22 2011-10-26 ジョージタウン・ユニバーシティ 全身性遺伝子送達のための抗体フラグメント標的化イムノリポソーム
US7780882B2 (en) 1999-02-22 2010-08-24 Georgetown University Simplified and improved method for preparing an antibody or an antibody fragment targeted immunoliposome for systemic administration of a therapeutic or diagnostic agent
US9034329B2 (en) 1999-02-22 2015-05-19 Georgetown University Preparation of antibody or an antibody fragment-targeted immunoliposomes for systemic administration of therapeutic or diagnostic agents and uses thereof
US7109165B2 (en) * 2001-05-18 2006-09-19 Sirna Therapeutics, Inc. Conjugates and compositions for cellular delivery
WO2004066908A2 (fr) * 2003-01-17 2004-08-12 Sanofi Pasteur Composition comprenant lipides cationiques et un polynucleotide ou un polpeptide et methode pour leur delivrance ciblee
JP2006517032A (ja) * 2003-01-28 2006-07-13 ジョージタウン・ユニバーシティ ある種の癌治療の有効性を評価するための方法
CN1327899C (zh) * 2003-05-10 2007-07-25 彭朝晖 腺病毒载体与p53基因的基因重组体的应用
CN1798545B (zh) * 2003-06-04 2013-06-05 乔治敦大学 改良脂质体复合物的稳定性和保存期的方法
US8627821B2 (en) 2005-01-10 2014-01-14 Pulmatrix, Inc. Method and device for decreasing contamination
US7858356B2 (en) * 2005-11-24 2010-12-28 Genomidea, Inc. Mutant paramyxovirus and method for production thereof
JP2009537526A (ja) 2006-05-15 2009-10-29 ジョージタウン・ユニバーシティ 治療もしくは診断剤の全身投与のための抗体もしくは抗体断片標的化免疫リポソームの製造およびその使用
CN102133404B (zh) * 2011-03-23 2013-01-16 成都诺恩生物科技有限公司 一种肿瘤靶向治疗药物载体、其制备方法及其应用
CA2857604A1 (en) 2011-12-22 2013-06-27 Nuvo Research Gmbh Liposomal chlorite or chlorate compositions
TWI614034B (zh) 2012-09-19 2018-02-11 美國喬治城大學 經靶向之脂質體
US20140120157A1 (en) 2012-09-19 2014-05-01 Georgetown University Targeted liposomes
KR20150131263A (ko) 2013-03-14 2015-11-24 조지타운 유니버시티 신경 작용제에 대한 노출을 위한 치료
ES2863773T3 (es) 2015-10-08 2021-10-11 Univ Utah Res Found Métodos y composiciones para prevenir o tratar el cáncer
WO2018087720A1 (en) 2016-11-14 2018-05-17 Novartis Ag Compositions, methods, and therapeutic uses related to fusogenic protein minion

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5635380A (en) * 1994-01-18 1997-06-03 Vanderbilt University Enhancement of nucleic acid transfer by coupling virus to nucleic acid via lipids
US5928944A (en) * 1994-02-04 1999-07-27 The United States Of America As Represented By The Department Of Health And Human Services Method of adenoviral-medicated cell transfection
CZ74797A3 (en) * 1994-09-13 1997-08-13 Theratech Composition for specific intracellular introduction of a chemical agent and method of such introduction
US20020051767A1 (en) * 1995-09-13 2002-05-02 Yawen L. Chiang Cancer treatment
JPH09110722A (ja) * 1995-10-20 1997-04-28 Toray Ind Inc 抗腫瘍活性物質の腫瘍細胞内導入用イムノリポソーム及びその調製法
WO1997028817A1 (en) * 1996-02-09 1997-08-14 Cheng Pi Wan Receptor ligand-facilitated delivery of biologically active molecules
JP3956402B2 (ja) * 1996-03-04 2007-08-08 日本油脂株式会社 アンホテリシンｂ運搬体

Also Published As

Publication number Publication date
DE69841536D1 (de) 2010-04-15
CN1904055A (zh) 2007-01-31
HK1035490A1 (en) 2001-11-30
HK1045641B (zh) 2010-10-29
HK1045641A1 (en) 2002-12-06
CA2308584C (en) 2011-07-19
HK1078608A1 (en) 2006-03-17
JP2010263920A (ja) 2010-11-25
EP1032369A1 (en) 2000-09-06
DK1166775T3 (da) 2010-05-03
EP1032369B1 (en) 2005-05-18
ATE459340T1 (de) 2010-03-15
ATE295722T1 (de) 2005-06-15
CA2308584A1 (en) 1999-05-27
CN1616665A (zh) 2005-05-18
WO1999025320A1 (en) 1999-05-27
CN1191094C (zh) 2005-03-02
CN1286630A (zh) 2001-03-07
JP2001522871A (ja) 2001-11-20
ES2339421T3 (es) 2010-05-20
EP1166775A2 (en) 2002-01-02
AU759164C (en) 2007-03-29
AU1464299A (en) 1999-06-07
CN1616665B (zh) 2010-10-06
EP1166775A3 (en) 2003-06-25
EP1166775B1 (en) 2010-03-03
DE69830249D1 (de) 2005-06-23
DE69830249T2 (de) 2006-05-04
AU759164B2 (en) 2003-04-10

Similar Documents

Publication Publication Date Title
HK1078608A1 (en) Targeted liposome gene delivery
AU9692498A (en) Complex of biotinylated viral vector and ligand for targeted gene delivery
AU9676198A (en) Drug delivery and gene therapy delivery system
WO1997038010A3 (en) Fusogenic liposomes
ZA200105505B (en) Small particle liposome aerosols for delivery of anti cancer drugs.
WO1999010014A3 (en) Receptor-mediated gene delivery using bacteriophage vectors
AU6535096A (en) Methods and means for targeted gene delivery
AU5700094A (en) Modified cutinases, dna, vector and host
GB9721909D0 (en) Gene delivery vectors and their uses
IL153853A0 (en) Bifunctional molecules and vectors complexed therewith for targeted gene delivery
WO1998030709A3 (en) Non-immunogenic prodrugs and selectable markers for use in gene therapy
MY138257A (en) Compositions and methods for enhancing delivery of therapeutic agents to cells
EP0911397A4 (en) TUMORANTANT PROTEINS, THEIR GENES, AND TUMORANTANT PEPTIDES
WO1998010750A3 (en) Nucleic acid particle delivery
AU4089899A (en) Stable envelope proteins for retroviral, viral and liposome vectors and use in gene and drug therapy
ZA991102B (en) Gene transfer-mediated angiogenesis therapy and techniques for intravascular gene delivery.
NZ510154A (en) A tumour antigen protein and gene therefor, tumour antigen peptides and derivatives thereof in medicaments and prophylactics
AU9269898A (en) Artificial viruses derived from papillomavirus, and their uses, in particular gene therapy
DE69704269D1 (de) Dendritische, lysinhaltige Polypeptide zur gezielten Arzneimittelabreichung
AU6987696A (en) The use of the wap of mmtv regulatory sequences for targeted expression of linked heterologous genes in human mammary cells, including human mammary carcinoma cells
AP2006003504A0 (en) Outer surface proteins, their genes, and their use.
EP1041146A4 (en) TUMOR ANTIGEN PROTEIN, ITS GENE AND ITS USE
NZ516777A (en) Method for delivery of therapeutic agents, particularly nucleic acids, using a solution of dextrin
MXPA01012500A (es) Productos para terapia de gen.
EP1033402A4 (en) P16 BINDING PROTEINS, GENE OF SUCH PROTEINS AND ANTIBODIES AGAINST THESE PROTEINS